Interestingly, compounds identified from the Enamine’s screening collection can inhibit GSK3β-dependent Tau phosphorylation and reduce Tau aggregation in human neuroblastoma SH-SY5Y cells expressing Tau repeat domain (TauRD) with pro-aggregation mutation ΔK280 (Chiang et al., 2021). Here, MAPT is linked to neuroblastoma.